Optimism over vaccines administered via mucosal surfaces

Lancet

Volumn 351, Issue 9113, 1998, Pages 1375-1376

  Levine, M M ^a   Dougan, G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; MALARIA VACCINE; TYPHOID VACCINE; VACCINE;

PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032499485     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79439-3     Document Type: Note

References (18)

1. MM Levine JB Kaper Live oral cholera vaccine: from principle to product Bull Inst Pasteur 93 1995 243 253
2. I Perez-Schael MJ Guntinas M Perez Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela N Engl J Med 337 1997 1181 1187
3. Belshe RB, Mendelman PM, Treanor J, et al. Efficacy of trivalent live attenuated intranasal influenza vaccine in children. N Engl J Med (in press).
4. C Gonzalez D Hone F Noriega Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans J Infect Dis 169 1994 927 931
5. GH Lowell Proteosomes for improved nasal, oral or injectable vaccines Levine MM Woodrow GC Kaper JB Cobon GS New generation vaccines 2nd edn. 1997 Marcel Dekker New York 193 206
6. H Aggerbeck S Gizurarson J Wantzin I Heron Intranasal booster vaccination against diphtheria and tetanus in man Vaccine 15 1997 307 316
7. JE Galen OG Gomez-Duarte GA Losonsky A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens Vaccine 15 1997 700 708
8. G Douce C Turcotte I Cropley Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic mucosal adjuvants Proc Natl Acad Sci USA 92 1995 1644 1648
9. BL Dickinson JD Clements Dissociation of Escherichia coli heat-labile enterotoxin adjucanticity from ADP-ribosyltransferase activity Infect Immun 63 1995 1617 1623
10. MM Giuliani G Del Guidice V Gianelli Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity J Exp Med 187 1998 1123 1132
11. GM Glenn M Rao GR Matyas CR Alving Skin immunization made possible by cholera toxin Nature 391 1998 851
12. LC Agren B Ekman L. Lowenadler NY Lycke Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit J Immunol 158 1997 3936 3946
13. CM Snapper JJ Mond A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens J Immunol 157 1996 2229 2233
14. CO Tacket MB Sztein GA Losonsky Safety and immune response in humans of live oral Salmonella typhi vaccine strains deleted in htrA and aroC, aroD Infect Immun 65 1997 452 456
15. EL Hohmann CA Oletta KP Killeen SI Miller phoP/phoQ -deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers J Infect Dis 173 1996 1408 1414
16. A Darji CA Guzman B Gerstel Oral somatic transgene vaccination using attenuated S typhimurium. Cell 91 1997 765 775
17. CO Tacket HS Mason G Losonsky JD Clements MM Levine CJ Arntzen Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato Nature 4 1998 607 609
18. TJ John P Jayabal Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference Am J Epidemiol 96 1972 263 269